Joseph P. Lucia & Associates’s Gilead Sciences GILD Stock Holding History

Joseph P. Lucia & Associates’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-425	Closed	-$26K	–	227
2022 Q2	$26K	Hold	425	–	–	0.02%	222
2022 Q1	$25K	Buy	+425	New	+$27.2K	0.02%	242
2021 Q4	–	Sell	-500	Closed	-$35K	–	278
2021 Q3	$35K	Hold	500	–	–	0.02%	249
2021 Q2	$34K	Hold	500	–	–	0.02%	251
2021 Q1	$32K	Hold	500	–	–	0.01%	242
2020 Q4	$29K	Buy	+500	New	+$30.2K	0.02%	228
2020 Q3	–	Sell	-737	Closed	-$57K	–	219
2020 Q2	$57K	Buy	737 +200	+37%	+$15.3K	0.05%	164
2020 Q1	$40K	Buy	537 +85	+19%	+$5.87K	0.04%	173
2019 Q4	$29K	Hold	452	–	–	0.03%	216
2019 Q3	$29K	Hold	452	–	–	0.03%	214
2019 Q2	$31K	Sell	452 -19,896	-98%	-$1.31M	0.03%	213
2019 Q1	$302	Buy	+20,348	New	+$1.35M	0.02%	191

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Joseph P. Lucia & Associates's GILD Position: Q3 2022 in Review

Joseph P. Lucia & Associates sold out of Gilead Sciences (GILD) in Q3 2022, closing a stake of 425 shares — an estimated $26K sold.

Joseph P. Lucia & Associates first reported a position in GILD in Q1 2019 and held it in 12 quarters. The position peaked at $57K in Q2 2020. 1,602 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

Joseph P. Lucia & Associates reported no remaining Gilead Sciences position as of Q3 2022 after selling out during the quarter.
Joseph P. Lucia & Associates sold 425 Gilead Sciences shares in Q3 2022, an estimated $26K.
Joseph P. Lucia & Associates first reported a position in Gilead Sciences in Q1 2019 and held it in 12 quarters.
Joseph P. Lucia & Associates's Gilead Sciences position peaked at $57K in Q2 2020.
1,602 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on Joseph P. Lucia & Associates's 13F filing for Q3 2022, filed 28 Oct 2022.